Meghmani Organics Limited (IN:MOL)
:MOL
Want to see IN:MOL full AI Analyst Report?
MOL Stock Chart & Stats
₹64.79
₹1.94(2.47%)
At close: 4:00 PM EST
₹64.79
₹1.94(2.47%)
Day’s Range― - ―
52-Week Range₹36.41 - ₹106.03
Previous CloseN/A
Volume1.74M
Average Volume (3M)53.48K
Market Cap
₹12.71B
Enterprise Value₹20.71B
Total Cash (Recent Filing)₹412.99M
Total Debt (Recent Filing)₹8.41B
Price to Earnings (P/E)―
Beta1.38
Next Earnings
May 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding254,314,210
10 Day Avg. Volume52,595
30 Day Avg. Volume53,476
Financial Highlights & Ratios
PEG Ratio1.75
Price to Book (P/B)1.10
Price to Sales (P/S)0.78
P/FCF Ratio-73.36
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.8
Revenue Forecast (FY)₹26.10B
Bulls Say, Bears Say
Bulls Say
Diversified Product MixMeghmani's mix of pigments and agrochemicals serves multiple end markets (coatings, plastics, inks, textiles, agriculture). This B2B diversification reduces single-market cyclicality, supports steadier order flow, and creates multiple durable revenue channels over months.
Improving EBIT MarginAn improving EBIT margin signals operational leverage and better cost absorption. If sustained through process improvements or scale, it supports longer-term profitability even if top-line pressure persists, improving the firm's ability to fund operations and reduce break-even risk.
Moderate Equity RatioA moderate equity ratio provides a structural capital cushion versus highly equity-concentrated peers, offering some solvency protection. This balanced financing mix can help absorb shocks and supports access to credit compared with a very thin equity base.
Bears Say
Declining Revenue And Net LossSustained revenue decline and a recent net loss indicate erosion of scale and pricing or volume pressure. Over months this impairs margin recovery, reduces internal funding for R&D or capex, and challenges the company's ability to restore profitable growth without structural fixes.
High LeverageElevated debt-to-equity increases interest and refinancing vulnerability, limiting strategic flexibility. Over a 2-6 month horizon higher leverage can force prioritization of cash for debt service, constrain investments, and amplify downside in adverse market or rate environments.
Negative Free Cash FlowPersistent negative free cash flow means core operations do not self-fund required investments. Reliance on external financing raises liquidity and covenant risk, and if unresolved it undermines the firm's ability to deleverage or invest in productivity improvements over the medium term.
Meghmani Organics Limited News
MOL FAQ
What was Meghmani Organics Limited’s price range in the past 12 months?
Meghmani Organics Limited lowest stock price was ₹36.41 and its highest was ₹106.03 in the past 12 months.
What is Meghmani Organics Limited’s market cap?
Meghmani Organics Limited’s market cap is ₹12.71B.
When is Meghmani Organics Limited’s upcoming earnings report date?
Meghmani Organics Limited’s upcoming earnings report date is May 09, 2026 which is in 9 days.
How were Meghmani Organics Limited’s earnings last quarter?
Meghmani Organics Limited released its earnings results on Jan 31, 2026. The company reported -₹0.139 earnings per share for the quarter, missing the consensus estimate of N/A by -₹0.139.
Is Meghmani Organics Limited overvalued?
According to Wall Street analysts Meghmani Organics Limited’s price is currently Overvalued.
Does Meghmani Organics Limited pay dividends?
Meghmani Organics Limited pays a Annually dividend of ₹1.4 which represents an annual dividend yield of N/A. See more information on Meghmani Organics Limited dividends here
What is Meghmani Organics Limited’s EPS estimate?
Meghmani Organics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Meghmani Organics Limited have?
Meghmani Organics Limited has 254,314,210 shares outstanding.
What happened to Meghmani Organics Limited’s price movement after its last earnings report?
Meghmani Organics Limited reported an EPS of -₹0.139 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.569%.
Which hedge fund is a major shareholder of Meghmani Organics Limited?
Currently, no hedge funds are holding shares in IN:MOL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Meghmani Organics Limited
Meghmani Organics Limited manufactures and sells pigments and agrochemicals in India and internationally. It offers green and blue pigments, which are used in printing inks, paints and coatings, and plastics. The company also provides agrochemical products comprises insecticides, which include cypermethrin, chlorpyriphos, alpha cypermethrin, permethrin, bifenthrin, lambda-cyhalothrin, deltamethrin, profenophos, acetamiprid, emamectin benzoate, and fipronil; herbicides, such as triclopyr butoxy ethyl ester, as well as 2,4-D acid tech, sodium salt WP/SP, and EsterTech; intermediates, including cypermethric acid chloride, meta phenoxy benzaldehyde, meta phenoxy benzyl alcohol, monochloroacetic acid, high trans cypermethric acid chloride, and high cis cypermethric acid chloride; and technical and formulations that are used in crop protection, veterinary, public health, and wood protection applications. Meghmani Organics Limited was founded in 1986 and is based in Ahmedabad, India.
Technical Analysis
DCW Ltd.
―
Fineotex Chemical Limited
―
IOL Chemicals & Pharmaceuticals Ltd.
―
Tatva Chintan Pharma Chem Limited
―
Tamil Nadu Newsprint & Papers Ltd.
―